Glucagon-Like Peptide-1 Receptor Agonists Combined With Personalized Digital Health Care for the Treatment of Metabolic Syndrome in Adults With Obesity: Retrospective Observational Study. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.